Insight: 2026 May See a "Crypto Winter," but Institutionalization and On-chain Transformation are Accelerating
BlockBeats News, December 29th, Cantor Fitzgerald pointed out in its latest year-end report that Bitcoin may be entering a prolonged multi-month downward cycle, with the market possibly stepping into an early "crypto winter" in 2026. Analyst Brett Knoblauch believes that Bitcoin has fallen back from this cycle's peak for about 85 days, and the price may continue to be under pressure, even testing the Strategy's average cost line around $75,000.
However, unlike previous cycles, this downward cycle is unlikely to be accompanied by a large-scale liquidation or systemic collapse. Cantor notes that the current market is dominated by institutions rather than retail investors, and the "divergence" between token price performance and on-chain fundamentals is widening, especially in the DeFi, tokenized assets, and crypto infrastructure sectors.
On the regulatory front, the passage of the U.S. "Digital Asset Market Structure Clarity Act" is seen as a key turning point, expected to reduce policy uncertainty and drive banks and asset management institutions to more deeply engage in the crypto market.
Cantor concluded that although 2026 may not usher in a new bull market, the institutionalization of the crypto industry, compliance pathways, and on-chain infrastructure are gradually solidifying while the price cools down.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Guoyuan International: Maintains Buy Rating on Shuidi (WDH.US), AI-Driven Rapid Performance Growth
After Waterdrop (WDH.US) released its Q2 2026 results, Guoyuan International issued a research report maintaining a "Buy" rating on Waterdrop with a target price of $1.25.

Market Chatter: Walmart, Scan Health Plan Collaborate on Medicare Advantage Plan
TD Cowen Initiates Arcus Biosciences at Buy
Social Buzz: Wallstreetbets Stocks Mostly Higher Premarket Wednesday; Broadcom, Micron Technology to Advance
